Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy

Contag, 2000, Use of reporter genes for optical measurements of neoplastic disease in vivo, Neoplasia, 2, 41, 10.1038/sj.neo.7900079 Edinger, 2002, Advancing animal models of neoplasia through in vivo bioluminescence imaging, Eur J Cancer, 38, 2128, 10.1016/S0959-8049(02)00410-0 Day, 2004, Evolution of beetle bioluminescence: the origin of beetle luciferin, Luminescence, 19, 8, 10.1002/bio.749 Choy, 2003, Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging, Biotechniques, 35, 1022, 10.2144/03355rr02 Paroo, 2004, Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden, Mol Imaging, 3, 117, 10.1162/1535350041464865 Nogawa, 2005, Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models, Cancer Lett, 217, 243, 10.1016/j.canlet.2004.07.010 Rehemtulla, 2000, Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging, Neoplasia, 2, 491, 10.1038/sj.neo.7900121 Szentirmai, 2006, Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect, Neurosurgery, 58, 365, 10.1227/01.NEU.0000195114.24819.4F Nyati, 2002, The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model, Gene Ther, 9, 844, 10.1038/sj.gt.3301706 Smakman, 2004, Validation of bioluminescence imaging of colorectal liver metastases in the mouse, J Surg Res, 122, 225, 10.1016/j.jss.2004.05.021 Mandl, 2004, Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome, Mol Imaging, 3, 1, 10.1162/153535004773861679 Jenkins, 2003, Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis, Clin Exp Metastasis, 20, 733, 10.1023/B:CLIN.0000006815.49932.98 Scatena, 2004, Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer, Prostate, 59, 292, 10.1002/pros.20003 Zeamari, 2004, In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats, Br J Cancer, 90, 1259, 10.1038/sj.bjc.6601637 Edinger, 2003, Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging, Blood, 101, 640, 10.1182/blood-2002-06-1751 Shah, 2004, Overriding imatinib resistance with a novel ABL kinase inhibitor, Science, 305, 399, 10.1126/science.1099480 Wu, 2005, Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo, Proc Natl Acad Sci U S A, 102, 10640, 10.1073/pnas.0504512102 Weisberg, 2005, Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl, Cancer Cell, 7, 129, 10.1016/j.ccr.2005.01.007 Yoshimitsu, 2004, Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors, Proc Natl Acad Sci U S A, 101, 16909, 10.1073/pnas.0407572101 Carlsen, 2002, In vivo imaging of NF-kappa B activity, J Immunol, 168, 1441, 10.4049/jimmunol.168.3.1441 Inoue, 2006, Light emission requires exposure to the atmosphere in ex vivo bioluminescence imaging, Mol Imaging, 5, 53, 10.2310/7290.2006.00015 Haishi, 2001, Development of a 1.0 T MR microscope using a Nd-Fe-B permanent magnet, Magn Reson Imaging, 19, 875, 10.1016/S0730-725X(01)00400-3 Inoue, 2006, Imaging of living mice using a 1-T compact magnetic resonance imaging system, J Magn Reson Imaging, 24, 901, 10.1002/jmri.20713 Garbow, 2004, MRI measurement of liver regeneration in mice following partial hepatectomy, Magn Reson Med, 52, 177, 10.1002/mrm.20107 Inderbitzin, 2004, Magnetic resonance imaging provides accurate and precise volume determination of the regenerating mouse liver, J Gastrointest Surg, 8, 806, 10.1016/j.gassur.2004.07.013 Allegrini, 1990, Course of murine leukemia retrovirus infection determined in vivo by magnetic resonance imaging, Lab Invest, 63, 568 Inoue, 2006, In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals, Eur J Nucl Med Mol Imaging, 33, 557, 10.1007/s00259-005-0048-4 Copelan, 1995, The biology and treatment of acute lymphoblastic leukemia in adults, Blood, 85, 1151, 10.1182/blood.V85.5.1151.bloodjournal8551151 Li, 1999, The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity, J Exp Med, 189, 1399, 10.1084/jem.189.9.1399 Reimer, 2004, Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications, Eur Radiol, 14, 559, 10.1007/s00330-004-2236-1 Rice, 2001, In vivo imaging of light-emitting probes, J Biomed Opt, 6, 432, 10.1117/1.1413210 El Hilali, 2002, Combined noninvasive imaging and luminometric quantification of luciferase-labeled human prostate tumors and metastases, Lab Invest, 82, 1563, 10.1097/01.LAB.0000036877.36379.1F Honigman, 2001, Imaging transgene expression in live animals, Mol Ther, 4, 239, 10.1006/mthe.2001.0437 Burgos, 2003, Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice, Biotechniques, 34, 1184, 10.2144/03346st01 Kreft, 1993, Enhancement of tumor-liver contrast-to-noise ratio with gadobenate dimeglumine in MR imaging of rats, J Magn Reson Imaging, 3, 41, 10.1002/jmri.1880030109 Kim, 2004, Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions, Eur Radiol, 14, 5, 10.1007/s00330-003-2115-1 Gauvain, 2005, MRI detection of early bone metastases in b16 mouse melanoma models, Clin Exp Metastasis, 22, 403, 10.1007/s10585-005-1264-9